303 related articles for article (PubMed ID: 18549256)
1. Evaluation of three principally different intact protein prefractionation methods for plasma biomarker discovery.
Pernemalm M; Orre LM; Lengqvist J; Wikström P; Lewensohn R; Lehtiö J
J Proteome Res; 2008 Jul; 7(7):2712-22. PubMed ID: 18549256
[TBL] [Abstract][Full Text] [Related]
2. Efficient prefractionation of low-abundance proteins in human plasma and construction of a two-dimensional map.
Cho SY; Lee EY; Lee JS; Kim HY; Park JM; Kwon MS; Park YK; Lee HJ; Kang MJ; Kim JY; Yoo JS; Park SJ; Cho JW; Kim HS; Paik YK
Proteomics; 2005 Aug; 5(13):3386-96. PubMed ID: 16047310
[TBL] [Abstract][Full Text] [Related]
3. Reversed-phase high-performance liquid chromatographic prefractionation of immunodepleted human serum proteins to enhance mass spectrometry identification of lower-abundant proteins.
Martosella J; Zolotarjova N; Liu H; Nicol G; Boyes BE
J Proteome Res; 2005; 4(5):1522-37. PubMed ID: 16212403
[TBL] [Abstract][Full Text] [Related]
4. Different immunoaffinity fractionation strategies to characterize the human plasma proteome.
Gong Y; Li X; Yang B; Ying W; Li D; Zhang Y; Dai S; Cai Y; Wang J; He F; Qian X
J Proteome Res; 2006 Jun; 5(6):1379-87. PubMed ID: 16739989
[TBL] [Abstract][Full Text] [Related]
5. Affinity prefractionation for MS-based plasma proteomics.
Pernemalm M; Lewensohn R; Lehtiö J
Proteomics; 2009 Mar; 9(6):1420-7. PubMed ID: 19235168
[TBL] [Abstract][Full Text] [Related]
6. Direct tandem mass spectrometry reveals limitations in protein profiling experiments for plasma biomarker discovery.
Koomen JM; Li D; Xiao LC; Liu TC; Coombes KR; Abbruzzese J; Kobayashi R
J Proteome Res; 2005; 4(3):972-81. PubMed ID: 15952745
[TBL] [Abstract][Full Text] [Related]
7. Depletion of the high-abundance plasma proteins.
Fountoulakis M; Juranville JF; Jiang L; Avila D; Röder D; Jakob P; Berndt P; Evers S; Langen H
Amino Acids; 2004 Dec; 27(3-4):249-59. PubMed ID: 15592754
[TBL] [Abstract][Full Text] [Related]
8. Combination of affinity depletion of abundant proteins and reversed-phase fractionation in proteomic analysis of human plasma/serum.
Zolotarjova N; Mrozinski P; Chen H; Martosella J
J Chromatogr A; 2008 May; 1189(1-2):332-8. PubMed ID: 18154976
[TBL] [Abstract][Full Text] [Related]
9. Contribution of protein fractionation to depth of analysis of the serum and plasma proteomes.
Faca V; Pitteri SJ; Newcomb L; Glukhova V; Phanstiel D; Krasnoselsky A; Zhang Q; Struthers J; Wang H; Eng J; Fitzgibbon M; McIntosh M; Hanash S
J Proteome Res; 2007 Sep; 6(9):3558-65. PubMed ID: 17696519
[TBL] [Abstract][Full Text] [Related]
10. New method for prefractionation of plasma for proteomic analysis.
Fitzgerald A; Walsh BJ
Electrophoresis; 2010 Oct; 31(21):3580-5. PubMed ID: 20931617
[TBL] [Abstract][Full Text] [Related]
11. Unravelling in vitro variables of major importance for the outcome of mass spectrometry-based serum proteomics.
West-Nørager M; Kelstrup CD; Schou C; Høgdall EV; Høgdall CK; Heegaard NH
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):30-7. PubMed ID: 17112795
[TBL] [Abstract][Full Text] [Related]
12. Multicolumn separation platform for simultaneous depletion and prefractionation prior to 2-DE for facilitating in-depth serum proteomics profiling.
Jmeian Y; El Rassi Z
J Proteome Res; 2009 Oct; 8(10):4592-603. PubMed ID: 19670910
[TBL] [Abstract][Full Text] [Related]
13. Enrichment of low-molecular-weight proteins from biofluids for biomarker discovery.
Chertov O; Simpson JT; Biragyn A; Conrads TP; Veenstra TD; Fisher RJ
Expert Rev Proteomics; 2005 Jan; 2(1):139-45. PubMed ID: 15966859
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the combination of bead technology with SELDI-TOF-MS and 2-D DIGE for detection of plasma proteins.
Sihlbom C; Kanmert I; Bahr Hv; Davidsson P
J Proteome Res; 2008 Sep; 7(9):4191-8. PubMed ID: 18690747
[TBL] [Abstract][Full Text] [Related]
15. Comparison of three methods for fractionation and enrichment of low molecular weight proteins for SELDI-TOF-MS differential analysis.
De Bock M; de Seny D; Meuwis MA; Servais AC; Minh TQ; Closset J; Chapelle JP; Louis E; Malaise M; Merville MP; Fillet M
Talanta; 2010 Jun; 82(1):245-54. PubMed ID: 20685463
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive proteomics in yeast using chromatographic fractionation, gas phase fractionation, protein gel electrophoresis, and isoelectric focusing.
Breci L; Hattrup E; Keeler M; Letarte J; Johnson R; Haynes PA
Proteomics; 2005 May; 5(8):2018-28. PubMed ID: 15852344
[TBL] [Abstract][Full Text] [Related]
17. High-abundance protein depletion: comparison of methods for human plasma biomarker discovery.
Polaskova V; Kapur A; Khan A; Molloy MP; Baker MS
Electrophoresis; 2010 Jan; 31(3):471-82. PubMed ID: 20119956
[TBL] [Abstract][Full Text] [Related]
18. Reduction of the concentration difference of proteins in biological liquids using a library of combinatorial ligands.
Thulasiraman V; Lin S; Gheorghiu L; Lathrop J; Lomas L; Hammond D; Boschetti E
Electrophoresis; 2005 Sep; 26(18):3561-71. PubMed ID: 16167368
[TBL] [Abstract][Full Text] [Related]
19. In-depth proteomic profiling of the normal human kidney glomerulus using two-dimensional protein prefractionation in combination with liquid chromatography-tandem mass spectrometry.
Miyamoto M; Yoshida Y; Taguchi I; Nagasaka Y; Tasaki M; Zhang Y; Xu B; Nameta M; Sezaki H; Cuellar LM; Osawa T; Morishita H; Sekiyama S; Yaoita E; Kimura K; Yamamoto T
J Proteome Res; 2007 Sep; 6(9):3680-90. PubMed ID: 17711322
[TBL] [Abstract][Full Text] [Related]
20. Semi-targeted plasma proteomics discovery workflow utilizing two-stage protein depletion and off-line LC-MALDI MS/MS.
Juhasz P; Lynch M; Sethuraman M; Campbell J; Hines W; Paniagua M; Song L; Kulkarni M; Adourian A; Guo Y; Li X; Martin S; Gordon N
J Proteome Res; 2011 Jan; 10(1):34-45. PubMed ID: 20936781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
